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Abstract: The innate immune response to viral pathogens is critical in order to mobilize 
protective  immunity.  Cells  of  the  innate  immune  system  detect  viral  infection  largely 
through germline-encoded pattern recognition receptors (PRRs) present either on the cell 
surface or within distinct intracellular compartments. These include the Toll-like receptors 
(TLRs),  the  retinoic  acid-inducble  gene  I-like  receptors  (RLRs),  the  nucleotide 
oligomerization domain-like receptors (NLRs, also called NACHT, LRR and PYD domain 
proteins) and cytosolic DNA sensors. While in certain cases viral proteins are the trigger of 
these receptors, the predominant viral activators are nucleic acids. The presence of viral 
sensing  PRRs  in  multiple  cellular  compartments  allows  innate  cells  to  recognize  and 
quickly  respond  to  a  broad  range  of  viruses,  which  replicate  in  different  cellular 
compartments. Here, we review the role of PRRs and associated signaling pathways in 
detecting viral pathogens in order to evoke production of interferons and cytokines. By 
highlighting recent progress in these areas, we hope to convey a greater understanding  
of  how  viruses  activate  PRR  signaling  and  how  this  interaction  shapes  the  anti-viral 
immune response. 
Keywords: pattern recognition receptor; toll like receptor; nod like receptor; AIM2 like 
receptor; RIG-I like receptor; cytosolic DNA sensor; inflammasome; interferon; virus 
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1. Introduction  
Cells of the innate immune system utilize pattern recognition receptors (PRRs) to identify viral 
pathogens by engaging pathogen-associated molecular patterns (PAMPs). Once thought to be moieties 
found only on pathogens our understanding of PAMPs (pathogen associated molecular patterns) has 
expanded to include not only classical PAMPS such as lipopolysaccharides found on bacteria but also 
nucleic  acids.  Nucleic  acid  sensing  has  emerged  as  a  major  component  of  the  immune  systems  
anti-microbial arsenal. A diverse range of pathogens are sensed via recognition of their genomes or 
nucleic acids which accumulate during their replication. Nowhere is this more prevalent than in viral 
detection. PRRs respond to signatures present in viruses such as 5‟ triphosphate RNA, which is not 
normally  found  in  host  RNA  or to  nucleic  acids  such  as  viral  DNA  which  is  exposed to  sensors 
localized in the cytoplasm.  
Of the PRRs, the Toll-like receptors (TLRs) are perhaps the most extensively studied. TLRs are 
type 1 transmembrane proteins that traffic between the plasma membrane and endosomal vesicles. 
They are primarily responsible for detecting PAMPs in the extracellular environment. Those located 
on the plasma membrane are usually specific for hydrophobic lipids and proteins while those found in 
endosomes detect nucleic acids. This segregation appears intentional allowing innate cells to respond 
to components of the viral envelope such as fusion machinery at their surface. In contrast, nucleic 
acids are detected in the endosome where many viruses uncoat their genomes and enter the cytoplasm. 
Upon reaching the cytoplasm, viral components are subject to the scrutiny of the retinoic acid-inducble 
gene  I-like  receptors  (RLRs),  the  nucleotide  oligomerization  domain-like  receptors  (NLRs)  and 
cytosolic  DNA  sensors  such  as  members  of  the  AIM2  family.  Similar  to  TLRs,  RLRs  and  DNA 
sensors  regulate  transcription  factors  essential  for  the  production  of  interferons  and  cytokines.  In 
contrast, NLRs and AIM2 are mainly responsible for the maturation of IL-1β and IL-18 through the 
activation of caspase-1. Interestingly, the immature forms of IL-1β and IL-18 are induced by TLR 
signaling  while  NLRs  act  as  a  „checkpoint,‟  regulating  the  activation  and  release  of  these  potent 
effectors. In addition to the production of proinflammatory molecules, many classes of PRRs mobilize 
the adaptive immune response by increasing expression of MHC class II and inducing expression of 
the costimulatory molecules CD40, CD80 and CD86.  
2. The Toll-like Receptors 
The  Toll  protein  was  first  recognized  for  its  role  in  dorsal-ventral  patterning  of  Drosophila 
embryos. Later studies found it to be important for the adult fly‟s immune response to bacterial and 
fungal infections fueling the search for mammalian homologs. To date, 10 TLRs have been identified 
in humans, 13 in mice with TLRs 1-9 common to both. TLR1, TLR2, TLR4, TLR5 and TLR6 are 
located on the plasma membrane while TLR3, TLR7, TLR8, and TLR9 are endosomal. All TLRs share 
a  common  architecture  consisting  of  extracellular  leucine-rich  repeats  and  a  cytoplasmic 
Toll/Interleukin-1  Receptor  (TIR)  domain  [1].  These  receptors  signal  as  dimers,  differentially 
recruiting the adaptor proteins Mal (MyD88 adapter-like), also called TIRAP (TIR domain-containing 
adaptor  protein)  and  MyD88  (Myeloid  differentiation  primary  response  gene  88)  and/or  TRIF 
(TIR-domain-containing  adaptor  inducing  IFNβ)  and  TRAM  (Trif-related  adaptor  molecule)  [1]. Viruses 2011, 3                         
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Adaptors initiate signal  cascades culminating  in the activation of nuclear  factor kappa b (NF-κB), 
mitogen-activated protein kinase (MAPK) and interferon regulatory factors 1, 3, 5 and 7 (IRF-3, -5  
and -7) [2]. Together these transcription factors not only drive expression of interferons, cytokines and 
chemokines but also influence cellular maturation and survival.  
2.1. TLR Signaling 
With the exception of TLR3 all TLRs recruit MyD88 upon activation. In the case of TLR2 and 
TLR4, the Mal/TIRAP protein acts as a bridging adapter to recruit MyD88 to the activated receptor 
[3]. MyD88‟s death domain associates with and activates IL-1R-associated kinase 1 (IRAK-1) and/or 
IRAK-2. IRAK-4 also transiently interacts with this complex and is thought to phosphorylate IRAK-1. 
IRAK-1 is subsequently released and engages TNFα receptor-associated factor 6 (TRAF6). Activated 
TRAF6  is  capable  of  K63-linked  polyubiquitination  of  itself  and  other  proteins.  It  interacts  with 
NF-κB essential modulator (NEMO, also known as IKKγ), another of its ubiquitination targets, as well 
as  TGF-β-activated  kinase-1  (TAK1)  and  the  TAK1  binding  proteins  (TAB1,  TAB2  and  TAB3). 
NEMO  forms  a  complex  with  IKKα  and  IKKβ,  which  are  the  catalytic  kinases  responsible  for 
phosphorylating IκB. IκB binds to and sequesters NF-κB in the cytoplasm. Following phosphorylation, 
IκB is ubiquitinated and finally degraded by the proteasome releasing NF-κB to enter the nucleus and 
induce gene expression. Studies indicate that TAK1 plays an essential role in both the NF-κB and 
MAPK pathways by phosphorylating IKKβ and c-Jun N-terminal kinase (JNK), respectively [4,5]. 
TLR3 is incapable of recruiting MyD88 and instead interacts with the adaptor protein TIR-domain-
containing adapter-inducing interferon-β (TRIF). TRIF can directly bind TRAF6 and induce NF-κB in 
a manner similar to MyD88. In contrast to MyD88, TRIF is also able to recruit the protein receptor 
interacting  protein-1  (RIP-1).  RIP-1  synergizes  with  TRAF6  resulting  in  more  potent  NF-κB 
activation.  A  third  protein  recruited  to  TRIF  is  TRAF3.  TRAF3  associates  with  TANK  binding  
kinase-1 (TBK1) and IKKi and is essential for the production of type I interferon. TBK1 and IKKi 
mediate  this  production  by  phosphorylating  interferon  regulatory  factor-3  (IRF3)  and  IRF7.  
This allows them to dimerize and enter the nucleus where they cooperate with NF-κB and activator 
protein 1 (AP-1) to bring about target gene transcription. TLR4 can recruit TRIF through the adaptor  
TRIF-related adaptor molecule (TRAM) and can therefore signal through either pathway.  
A number of primary immunodeficiencies in humans are the result of defects in the innate signal 
pathways described above. For instance, one study of children with nonfunctional MyD88 proteins 
found they were predisposed to recurrent life-threatening pyogenic bacterial infections [6]. A similar 
phenotype has been reported in patients with IRAK-4 deficiency [7]. A study of two unrelated children 
with defects in UNC-93B1, a protein thought to be involved in trafficking TLR3, TLR7, TLR8 and 
TLR9  to  the  endosome,  found  an  increased  susceptibility  to  encephalitic  herpes  simplex  virus-1 
infection  [8].  PBMCs  and  fibroblasts  derived  from  these  children  demonstrated  a  reduced  type  I 
interferon response to HSV-1 challenge and a concomitant enhancement in viral replication [8]. 
2.2. TLR Expression and Activity 
The inflammatory response evoked by viral PAMPs depends on a variety of factors. Firstly, cellular 
expression of TLRs differs between innate cell types. Human macrophages are known to express high Viruses 2011, 3                         
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levels  of  TLR2  and  TLR4  while  plasmacytoid  dendritic  cells  (pDCs)  mainly  express  TLR7  and 
TLR9 [1]. Expression patterns also vary between species, where TLR9 is restricted to a few cell types 
in humans it is widely distributed in mice. Furthermore, expression of certain downstream signaling 
molecules  fluctuates  between  innate  cell  types.  For  example,  pDCs  are  unique  in  that  they 
constitutively express the transcription factor IRF7 allowing them to quickly produce high levels of 
type I IFNs in response to viral infection while other cell types such as macrophages may respond in a 
more delayed manner [2,3]. Thus, the response to identical viral PAMPs may differ between cell types 
both in the nature of effector molecules produced and the kinetics of the response. Virally encoded 
proteins  that  subvert  or  distort  the  TLR  response  often  further  complicate  this  picture.  In  the 
subsequent sections we discuss the TLRs individually, detailing the viruses they detect and wherever 
possible the specific viral products sensed. 
2.3. TLR4 
The TLR4-mediated response to LPS is well known for its critical role in innate immune control of 
Gram-negative bacterial infection. It was also the first TLR shown to respond to a viral pathogen. In 
2000, Kurt-Jones et al. reported the interaction between the fusion (F) protein of respiratory syncytial 
virus (RSV) and TLR4 [4]. The importance of TLR4 in human viral disease and RSV pathogenesis has 
been  documented  in  genetic  studies.  In  humans,  inheritances  of  two  different  single  nucleotide 
polymorphisms (SNPs) in the ectodomain of TLR4 are associated with reduced responses to both LPS 
and RSV F. A highly significant association was found between RSV infection in high-risk infants and 
inheritance of hyporesponsive TLR4 SNPs [5]. This was confirmed in a separate study that likewise 
found  a  significant  association  between  these  same  TLR4  SNPs  and  severity  of  RSV  disease  in 
infants [6].  
Initial  studies  linking  TLR4  expression  to  RSV  pathogenesis  were  done  in  the  TLR4-deficient 
mouse strain C57BL10ScNCr (which has a deletion of the gene region containing TLR4) as well as in 
C3H/HeJ mice (non-signaling point mutation of TLR4) [4,7]. These studies found that RSV activated 
NF-B in a TLR4-dependent manner at early time points of infection [8]. The original RSV infection 
studies with ScNCr mice were controversial as it was suggested that the failure to control RSV was 
due to a defect in IL-12R signaling [9]. However, this discrepancy between the different studies was 
due in part to confusion about the mouse nomenclature since the ScNCr mice used in the initial studies 
(but misidentified as ScCR in the paper [4]) have normal IL-12R [10] while the ScCr mice used by the 
second group were IL-12R-deficient [9]. More recent work using targeted TLR4 knockouts on a B6 
background (with normal IL-12R) have confirmed the role of TLR4 in controlling RSV replication 
independent of IL-12R, but interestingly these studies have also revealed an even more important role 
for TLR2 in limiting RSV replication [11]. The purified F protein of RSV induced IL-6 production in a 
dose-dependent manner in human peripheral blood mononuclear cells (PBMCs) and wild type mouse 
macrophages  alike.  However,  this  response  was  lost  in  TLR4  deficient  and  TLR4  knockout 
macrophages [4,11].  Studies  by  Vogel  and  colleagues  have  shown  that the  ability  of  TLR4  to be 
triggered by RSV F is critical to prevent RSV-induced pathology. Indeed, the formalin-inactivated 
RSV vaccine which caused exacerbated disease in clinical trials and was found to contain a denatured, 
non-stimulatory F protein. The disease enhancing activity of the formalin-inactivated RSV vaccine Viruses 2011, 3                         
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could be reversed by the addition of MPL, a non-toxic lipid A TLR4 agonist [12]. Disease severity is 
also correlated with the absence of “alternatively activated” (AA) macrophages that play a crucial role 
in tissue repair [13]. Taken together with the human and mouse genetics, these studies suggest that 
TLR4-F  protein  interactions  may  protect  the  host  from  severe  RSV  disease  by  mitigating  or 
reprogramming the host response to promote AA-macrophages and thus promote healing [14].  
TLR4 is also important for infections by the retrovirus mouse mammary tumor virus (MMTV). 
MMTV was shown to activate NF-B and induce B220 and CD69 lymphocyte activation markers in B 
cells  from  wild  type  but  not  C3H/HeJ  or  congenic  BALB/c  (C.C3H  Tlr4
lps-d)  lines [15].  TLR4 
activation, attributed to the envelope (Env) protein, was found to stimulate production of IL-10 [16]. 
Surprisingly induction of TLR4 signaling appears to benefit MMTV. First, it activates quiescent B 
cells  encouraging  cell  division,  which  is  necessary  for  viral  genome  integration  in  the  host 
chromosome. Secondly, it promotes secretion of IL-10, an immunosuppressive cytokine that helps the 
virus persist indefinitely [15].  
2.4. TLR2 
Functional TLR2 exists as a heterodimer with either TLR1 or TLR6 on the plasma membrane of 
both innate and adaptive immune cells. It can be activated by lipoteichoic acid, a common component 
of  gram-positive  bacteria,  as  well  as  GPI  anchors  of  parasitic  protozoan  such  as  Plasmodium 
falciparum. The TLR2/TLR6 heterodimer has recently been shown to play a role in the innate immune 
response to RSV. Macrophages from mice deficient in TLR2 or TLR6 responded to RSV with lower 
levels of TNF, IL-6, CCL2 (MCP-1) and CCL5 (RANTES) than their wild type counterparts. When 
TLR2 or TLR6 knockout mice were challenged intranasally with RSV they had elevated peak viral 
titers  and  lower  numbers  of  neutrophils  and  activated  DC  in  their  lungs [11].  Thus,  TLR2/TLR6 
signaling likely contributes to both innate immune cell recruitment and viral clearance in vivo during 
RSV infection [11]. In human PBMCs, TLR2 contributes to IL-8 and MCP-1 production in response to 
Epstein-Barr  virus  (EBV) [17].  A  TLR2/TLR1-mediated  proinflammatory  response  to  the  related 
human cytomegalovirus (HCMV) has also been reported. One study  found TLR2 deficient mouse 
macrophages  had  significantly  reduced  IL-6  and  IL-8  production  in  response  to  UV-inactivated 
HCMV [18]. Furthermore, expression of TLR2 and CD14 was required for maximal NF-B activation 
and IL-8 secretion in HEK293 cells exposed to HCMV. Envelope glycoproteins B and H were later 
shown to coimmunoprecipitate with TLR2 and TLR1 and are theorized to be the HCMV PAMPs 
stimulating TLR2 [19].  
Lymphocytic Choriomeningitis (LCMV) is a non-cytolytic virus that can cause fatal encephalitis in 
mice. Wild type glial cells infected with LCMV produce TNF, CCL2 and CCL5, a response that is 
abolished  in  cells  derived  from  TLR2  deficient  mice [20].  TLR2  also  induces  MHC  class-I  and  
class-II, CD40 and CD86 expression in microglia challenged with LCMV, implicating this pathway in 
the  induction of adaptive  immunity [20]. In LCMV  infection, where  much of the CNS damage  is 
caused by the immune response itself, it remains to be determined if TLR2 signaling is protective or 
pathological. Interestingly, TLR2 is important for type I IFN induction during LCMV infection but the 
mechanism is unclear [21]. Although TLR2 is normally not associated with type I IFN induction, a Viruses 2011, 3                         
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recent  study  from  Barton  and  colleagues  demonstrated  that  on  inflammatory  monocytes,  TLR2 
regulates induction of type I interferon in response to viral but not bacterial ligands [22].  
Surprisingly, it appears TLR2 can play either a protective or detrimental role in disease caused by 
herpes simplex virus (HSV) depending on the context of the infection. Studies using an intraperitoneal 
infection  model  found  TLR2  deficient  neonates  were  protected  from  lethal  HSV-1  encephalitis 
compared  to  wild  type  mice [23].  Despite  having  similar  viral  loads,  the  TLR2  knockouts 
demonstrated  improved  survival,  attenuated  symptoms  and  reduced  CNS  inflammatory  lesions.  In 
contrast, TLR2 was shown to work synergistically with TLR9 to promote survival in an intranasal 
HSV-1 infection model [24]. In addition, TLR2 has been shown to be beneficial in both intraperitoneal 
and intravaginal HSV-2 infection models [25]. TLR2‟s role in murine HSV infection models may be 
influenced by factors such as the size of the viral inoculum, the route of administration and the age of 
the subject. HSV induced two distinct responses; a TLR2-dependent inflammatory cytokine response 
and a TLR9 and/or non-TLR-dependent type I IFN response. A strong IFN response is necessary to 
control early virus replication (IFN-deficient mice quickly succumb to infection) and prevent spread 
from the genital tract to the brain [25]. Once in the brain, however, inflammation is linked to increased 
mortality [23].  
Measles virus (MV) is another infection in which TLR2 signaling may have both favorable and 
unfavorable  effects.  Challenging  mice  with  live  or  UV-inactivated  wild  type  MV  induces  IL-6 
production  and  CD150  surface  expression  in  mouse  macrophages;  a  response  that  is  impaired  in 
TLR2-deficient cells [26]. Intriguingly, CD150 is required for entry of wild type MV into monocytes, 
thus immune activation through TLR2 may in fact benefit the virus by conferring susceptibility. This 
study identified MV hemaglutinin (HA) protein as the viral PAMP triggering TLR2 activation [26]. 
MV vaccine strains carrying a single asparagine to tyrosine substitution in the HA protein lacked the 
ability to activate TLR2.  
2.5. TLR3 
With the exception of neutrophils and pDCs, TLR3 is widely expressed in innate immune cells 
where it is localized to the endosomal compartment [27,28]. In 2001, Alexopoulou et al. demonstrated 
that activation of TLR3 signaling by the double stranded RNA analog poly(I:C) contributed to the 
production of type I IFN and cytokines in macrophages. Moreover, genomic dsRNA isolated from 
reovirus was found to activate wild type but not TLR3 deficient splenocytes. The idea that TLR3 could 
respond  to  dsRNA,  a  common  viral  PAMP,  led  to  intense  speculation  about  its  role  in  the  host 
response to numerous infections. Counterintuitively, a later study found no difference in the survival, 
viral  titers  or  pathology  of  TLR3  deficient  mice  following  reovirus  challenge [29].  The  authors 
suggested that during in vivo infection, TLR3 may not encounter reovirus dsRNA or that levels may be 
too low to efficiently activate TLR3 [29]. This study also reported indistinguishable immune responses 
to LCMV, VSV and MCMV infection in TLR3 deficient and wild type mice [29]. However, other 
evidence exists suggesting that TLR3 does in fact play a role in controlling MCMV as some studies 
observed blunted type I IFN and IL-12 production accompanied by higher viral loads in the spleens of 
mice  lacking  TLR3 [30,31].  Despite  this,  only  TLR9  deficient  mice  had  significantly  decreased 
survival compared to wild type suggesting TLR9 is more crucial than TLR3 in MCMV infections [30]. Viruses 2011, 3                         
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A  recent  study  also  implicates  TLR3  in  immune  suppression  of  the  related  herpes  virus  HSV-1. 
Patients with TLR3 dominant negative mutations were found to be more susceptible to herpes simplex 
encephalitis, a rare but devastating manifestation of HSV-1 infection [32]. The presumed ligand for 
TLR3  in  infections  with  DNA  viruses  is  dsRNA  generated  during  bidirectional  transcription  of 
opposing DNA strands. TLR3 signaling also reduces lethality of encephalomyocarditis virus (EMCV), 
a ssRNA virus that directly damages heart tissue [33]. TLR3 deficient mice challenged with EMCV 
had decreased levels of TNF, IL-6 and IL-1 mRNA in cardiac tissue and a corresponding reduction 
in inflammatory infiltrate at 3 days post infection [33]. Without TLR3 signaling, EMCV replicated to 
higher levels in the heart resulting in more rapid and extensive mortality in knockouts [33].  
Although  this  study  indicates  that  the  TLR3-mediated  inflammatory  response  is  beneficial  in 
EMCV infections; TLR3 signaling appears to be detrimental in a number of other viral infections. For 
instance,  TLR3  deficient  mice  were  protected  compared  to  their  wild  type  counterparts  when 
challenged with a lethal dose of West Nile Virus (WNV) [34]. This study found that TLR3 driven 
production of inflammatory cytokines compromised the blood-brain barrier facilitating WNV entry. 
This resulted in higher viral loads in the CNS and worsened neuropathology. Likewise, TLR3 was 
shown to play a pathologic role in infections with Punta Toro Virus (PTV) [35]. Wild type mice had 
drastically reduced survival and increased hepatic injury compared to TLR3 deficient mice following 
PTV challenge. Despite having similar serum and hepatic viral loads, wild type mice had elevated 
levels of IL-6, IFN, CCL2 and  CCL5, suggesting these proinflammatory  molecules  may  mediate 
much of the damage observed [35]. Interestingly, although TLR3 signaling increases inflammation and 
reduces Influenza A virus (IAV) lung titers, it causes a paradoxical decrease in survival. Thus, in IAV 
infections, lethality appears to be more dependent on TLR3 signaling than direct virus-induced injury.  
2.6. TLR7 and TLR8 
TLR7 and TLR8 are two closely related receptors that, like TLR3, act in the endosome. Human 
TLR7  and  TLR8  were  first  shown  to  respond  to the  imidazoquinoline-like  compound  resiquimod  
(R-848), a synthetic drug recognized for its antiviral and antitumor activity [36,37]. We now know that 
nearly any long single-stranded RNA (ssRNA) is capable of activating TLR7 and TLR8 [38]. Despite 
this,  differences  do  exist  between  these  receptors.  For  example,  short  dsRNAs  containing  certain 
motifs preferentially activate TLR7 [39,40]. Furthermore, synthetic agonists specific to TLR7 or TLR8 
differentially  activate  innate  immune  cells  leading  to  distinct  cytokine  profiles [41].  In  2004,  
Diebold  et  al.  showed  that  TLR7  mediates  IFN  production  by  pDCs  in  response  to  live  or  
heat-inactivated  influenza  virus [42]. This TLR7 response could  be elicited simply  by  exposure to 
purified genomic ssRNA and was completely abrogated by chloroquine, an inhibitor of endolysosomal 
acidification [42].  Thus,  the  authors  proposed  a  model,  now  known  as  the  exogenous  pathway, 
whereby pDCs endocytose and degrade a portion of incoming influenza virions, allowing TLR7 to 
engage exposed genomic RNA. A similar TLR7-dependent type I interferon response was observed 
when pDCs were challenged with vesicular stomatitis virus (VSV) [43]. Under normal circumstances 
both influenza and VSV require endocytosis for viral entry. However, using a recombinant strain of 
VSV (VSV-RSV-F), capable of fusing to the plasma membrane, Lund et al. demonstrated that VSV 
activated TLR7 regardless of the route of viral entry. TLR7 is also responsible for pDC production of Viruses 2011, 3                         
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IFN  in  response  to  Sendai  virus  (SV);  another  ssRNA  virus  which  enters  at  the  plasma 
membrane [44]. Interestingly studies of SV using human U937 and murine RAW 264.7 myeloid lines 
found  only  a  partial  role  for  TLR  signaling  in  cytokine  and  chemokine  production [45].  Recent 
evidence suggests the cytosolic RLR receptors are chiefly responsible for the cytokine and interferon 
response to SV in myeloid cell types other than pDCs [46]. 
One  important  observation  gleaned  from  studies  using  SV  and  VSV  was  that,  in  contrast  to 
influenza, UV-inactivation of these virions abolished TLR7 activation [44]. From this work a second 
model of TLR7 activation known as the endogenous pathway was proposed. According to this theory, 
ssRNA intermediates produced during SV and VSV infection are transferred from the cytoplasm to the 
endosome by means of autophagy [44]. Thus, to elicit a TLR7 response by this route, cells must be 
exposed to live, replication competent virus. This model is supported by studies showing that selective 
inhibitors of autophagy and mice deficient in autophagic pathways lack a TLR7 mediated response to 
SV  and  VSV [44].  Recent  studies  have  implicated  TLR7  and  TLR8  in  the  response  to  human 
immunodeficiency  virus  (HIV).  ssRNA  derived  from  the  HIV  genome  caused  murine  pDCs  and 
macrophages and human PBMCs to produce IFN, IL-6 and TNF [47]. In mice this activity was 
TLR7-dependent while in humans it appears to rely on TLR8 suggesting that HIV receptors may be 
species-specific.  A  study  by  Wang  et  al.  found  IFN  production  by  human  and  mouse  pDCs 
responding to Coxsackievirus B (CVB) was also dependent on TLR7 [48]. Interestingly, this response 
required the presence of CVB-specific antibodies as well as functional Fc Receptor complexes on the 
pDC surface. Thus they proposed a mechanism whereby opsonized CBV is delivered to the endosome 
via FcR and once internalized viral RNA is detected by TLR7 [48]. This observation suggests previous 
exposure  to  CVB  can  influence  subsequent  innate  responses  furthering  our  understanding  of  the 
complex interplay between adaptive and innate immunity.  
2.7. TLR9  
In both humans and mice, TLR9 is highly expressed in pDCs, innate cells renowned for their ability 
to  rapidly  produce  large  amounts  of  type  I  interferon [1].  TLR9  responds  to  the  unmethylated 
deoxycytidylate-phosphate-deoxyguanylate  (CpG)  motifs  in  viral  and  bacterial  DNA [49].  Not 
surprisingly TLR9 has been shown to play a crucial role in infections caused by a number of DNA 
viruses. For instance, TLR9 deficient mice infected with MCMV have a drastically increased mortality 
compared to their wild type counterparts. This hypersensitivity is likely due to the blunted type I IFN 
and IL-12 response and reduced NK cell activation which results in an elevated MCMV load [30]. In 
EBV infection, production of type I IFN, IL-6 and IL-8 by pDCs is largely dependent on TLR9 [17]. 
This  is  in  contrast  to  monocytes  where  TLR2  synergizes  with  TLR9  to  orchestrate  the  cytokine 
response to EBV [17]. TLR9 signaling also plays a role in the interferon response to HSV types I and 
II. One study found IFN production by mouse pDCs in response to HSV-2 was completely dependent 
on  TLR9  and  independent  of  viral  replication [50].  Using  cholorquine  it  was  shown  that  this 
recognition  required  endosomal  maturation  and  could  be  evoked  simply  by  exposure  to  purified  
HSV-2 DNA [50]. Furthermore, following in vivo HSV-2 challenge, IFN was only detectable in the 
serum of mice with intact TLR9. A similar role for TLR9 was described in the response to HSV-1 by 
splenic pDCs. However, this study also described a delayed IFN response by conventional dendritic Viruses 2011, 3                         
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cells (cDCs) and macrophages that was both TLR9 and MyD88-independent but required exposure to 
replication competent virus. The TLR9-independent IFN response is likely due to cytoplasmic RLRs 
and may explain why one study using TLR9 deficient mice identified no in vivo defects in the HSV-1 
control [51]. Alternatively, TLR9 signaling may be more important in certain manifestations of HSV-1 
induced disease. A recent study showed TLR9 deficient mice did have higher rates of mortality and 
viral replication when challenged  intranasally with HSV-1 [24]. Thus TLR9‟s precise role  in HSV 
pathogenesis  and  the  relative  contributions  of  other  PRRs  requires  further  investigation.  Figure  1 
illustrates the TLRs activated by viral pathogens and depicts their downstream signal pathways. 
Figure 1. Cell surface and endosomal recognition of viruses by Toll-like receptors (TLRs). 
TLR2  responds  to  a  variety  of  viruses  resulting  in  activation  of  a  MyD88-dependent  
NF-κB  and  MAPK  pathway.  TLR4,  responding  to  viral  proteins  (e.g.,  RSV  F-protein) 
activates  both  a  MyD88-dependent  and  MyD88-independent  response.  The  MyD88-
dependent response leads to transcriptional regulation of inflammatory cytokines, while the 
MyD88-independent response is regulated via TRAM/TRIF and the IKK-related kinases 
which drive IRF3 activation and type I Interferon production.  In the endosome, TLR3, 
TLR7,  TLR8  and  TLR9  sense  viral  nucleic  acids  and  generate  either  IRF3  activation 
(TLR3) or IRF7-driven type I IFNs (TLR7, 8 and 9).  
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3. Intracellular Nucleic Acid Sensors 
As discussed above, the TLRs play an  important role  in  sensing  viral PAMPS that are present 
within the extracellular compartment, as well as in endosomes. In certain contexts, TLRs can receive 
viral  nucleic  acids  generated  from  viruses  that  replicate  in  the  cytoplasm,  via  an  autophagy 
mechanism. A role for intracellular sensors in the clearance of viruses that replicate and reside within 
the  cytosol  of  cells  has  recently  emerged.  Following  the  generation  of  mice  lacking  TLRs  and 
examination  of  their  susceptibility  to  virus  infections,  it  became  clear  that  additional  sensing 
mechanisms must also exist and contribute to anti-viral defenses. The last decade or more has revealed 
numerous additional classes of innate sensors. Of particular relevance to anti-viral defenses was the 
discovery of specialized classes of cytosolic nucleic acid sensors, termed RIG-I like receptors (RLRs), 
which  recognize  intracellular  RNA  that  is  introduced  to the  cytosol  during  viral  infection  or  that 
accumulates during replication. Additionally, a diverse selection of intracellular DNA sensors which 
recognize viral DNA within the cytosol have also emerged.  
3.1. The RIG-I like Receptor Family 
The RLR family is comprised of three DExD/H box RNA helicases: retinoic acid-inducible gene 
(RIG-I),  melanoma  differentiation-associated  gene  5  (MDA-5),  and  laboratory  of  genetics  and 
physiology-2 (LGP-2) [60–64]. Both RIG-I and MDA-5 are comprised of tandem N-terminal caspase 
activation and recruitment domains (CARDs) followed by a DExD/H box RNA helicase domain which 
has ATPase activity and a C-terminal repressor domain (RD). Unlike RIG-I and MDA-5, LGP-2 lacks 
the  N-terminal  CARD  domains,  containing  only  the  RNA  helicase  domain.  As  such,  LGP-2  was 
postulated to act as a negative regulator of the other RLRs [61,63]. Under resting conditions, RIG-I 
resides in the cytoplasm in an inactive form that is auto inhibited by its regulatory domain. Upon viral 
infection,  RIG-I  undergoes  a  conformational  change  by  which  it  dimerizes  in  an  ATP  dependent 
manner [63]. The activated multimeric form of RIG-I or MDA5 then interacts with the downstream 
adaptor protein mitochondrial antiviral signaling protein (MAVS), also known as VISA, IPS-1, and 
CARDIF, via CARD-CARD interactions. MAVS is localized to the outer leaflet of the mitochondrial 
membrane, which is an essential location to support downstream signaling. Recently, MAVS was also 
shown to be localized on peroxisomes, from where it induces an early antiviral response through the 
direct induction of a subset of anti-viral genes via the transcription factor IRF1. Upon engagement of 
RIG-I or MDA5 with MAVS, MAVS activates the IKK-related kinase, TBK1/IKKi, which activates 
IRF3/IRF7, resulting in the transcription of type I interferons. MAVS also activates NF-κB through 
recruitment of TRADD, FADD, caspase-8, and caspase-10 [65–69]. 
3.2. RNA Recognition by RLRs 
The RLRs are critical components of the anti-viral defense pathway in many cell types including 
fibroblasts, epithelial cells, and conventional dendritic cells [70]. Initially, it was thought that both 
RIG-I and MDA-5 recognized the synthetic dsRNA, polyinosinic acid (polyI:C). However, studies 
from RIG-I and MDA-5 deficient mice determined that MDA-5 alone was responsible for interferon 
production  by  polyI:C  stimulation  [71].  Instead,  RIG-I  recognizes  5‟-triphosphorylated,  uncapped Viruses 2011, 3                         
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ssRNA, which is a common feature in many viral genomes. However, it is unable to recognize the 
capped 5‟-ppp ssRNA from the host cell [72–74]. These finding suggest that RIG-I uses the 5‟ end of a 
transcript to discriminate between viral and host RNA. MDA-5 distinguishes between viral and host 
RNA not by its 5‟ end, but rather by the length of the RNA sequence; long dsRNA is not naturally 
present in host cells and acts as a ligand of MDA-5. In addition to recognizing 5‟-triphosphate RNA, 
RIG-I  is  also  capable  of  recognizing  short  dsRNA,  which  is  produced  as  a  byproduct  of  viral 
replication [75].  
RIG-I  and  MDA-5  appear  to  differentially  recognize  different  classes  of  RNA  viruses.  Studies 
involving RIG-I deficient mice implicated RIG-I in the recognition of vesicular stomatitis virus (VSV), 
rabies virus, SV, Newcastle disease virus (NDV), RSV, measles virus, Influenza A and B, hepatitis C 
virus  (HCV),  Japanese  encephalitis  virus,  and  ebola  virus  [53,70,71,76–78]. Studies  from  MDA-5 
deficient mice show that MDA-5 is able to recognize EMCV, theiler‟s virus, and mengo virus [71,77]. 
All of these viruses do not contain a 5‟ triphosphate RNA, but are able to produce long dsRNA, 
providing  further  evidence  that  MDA5  discriminates  between  self  and  non-self  RNA  based  on 
sequence length and not the 5‟triphosphate. More recently  studies have shown that both CVB and 
poliovirus  are  dependent  on  MDA-5  for  type  I  IFN  production  [79,80].  Moreover,  some  viruses,  
such  as  dengue,  West  Nile  virus,  and  reovirus,  signal  through  a  combination  of  both  RIG-I  and  
MDA-5 [79,81,82].  
As discussed above, LGP-2 lacks N-terminal CARD domains, and was first thought to be a negative 
regulator of RLR function [61,63]. Initial studies found that overexpression of LGP-2 decreased the 
capacity of SV and NDV to induce interferon production. Evidence that LGP-2 could associate with 
RIG-I through mutual RD domains led to the proposal that LGP-2 directly prevented RIG-I association 
and activation. Consistent with this idea, interferon signaling was found to be increased in LGP-2 
deficient mice responding to polyI:C, providing evidence for negative regulation of MDA-5 as well [83]. 
A second in vivo study using LGP-2 deficient mice as well as mice harboring an inactive ATPase in 
the DExD/H-box RNA helicase domain showed that LGP-2 acted as a positive regulator of RIG-I and 
MDA-5-mediated  signaling  after  infection  by  RIG-I  and  MDA-5-specific  RNA  viruses.  This 
phenotype  is  consistent  with  the  possibility  that  LGP-2  might  promote  RNA  accessibility,  thus 
enabling RIG-I or MDA-5 dependent viral recognition. Further studies on these mice will no doubt 
clarify this upstream mechanism and the role of LGP-2 in this pathway.  
3.3. DDX3 
Another  member  of  the  DExD/H  box  RNA  helicase  family,  DDX3,  has  also  recently  been 
implicated in anti-viral defenses. Schroder et al. found that the vaccinia virus protein K7 inhibited 
IFNβ induction by binding to DDX3, which led to the discovery that DDX3 had a positive role in the 
RLR signaling pathway [84]. A more recent study reported that DDX3 binds to both polyI:C and viral 
RNA introduced into the cytosol and associates with MAVS/IPS-1 to upregulate IFNβ production. 
These results  led the authors to speculate that DDX3  might enhance  RNA recognition,  forming a 
complex with RIG-I and MAVS to induce interferon production [85]. Further studies are required to 
determine whether DDX3 is a bona fide RNA sensor or a component of the RLR signaling pathway in 
order to fully understand the function DDX3 plays in anti-viral surveillance and signaling.  Viruses 2011, 3                         
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3.4. Cytosolic DNA Sensors 
Prior to the discovery of TLR9, it was known that DNA derived from pathogens could activate 
fibroblasts to produce type I IFNs [86]. This phenomenon was ignored or underestimated for decades 
and was rediscovered following the observation that transfection of pathogen-derived dsDNA activated 
a  TLR9  negative  thyroid  cell  line  to  upregulate  various  immunological  genes  [87].  Akira  and 
colleagues subsequently demonstrated that TLR9−/− MEFs, which failed to respond to CpG DNA, 
produced large amounts of IFN in response to transfection with synthetic b-form dsDNA or genomic 
DNA isolated from bacteria, viruses, and mammalian cells [87]. This was similar to findings presented 
by  the  Medzhitov  lab  using  a  45  bp  dsDNA  region  from  the  Listeria  monocytogenes  genome. 
Cytosolic administration of dsDNA did not appear to utilize any known TLRs to induce interferon 
since cells from mice lacking both MyD88 and TRIF responded normally.  
Like the cytosolic RNA recognition pathways, cytosolic DNA recognition also leads ultimately to 
activation of TBK1 and IRF-3 and production of type I IFNs. However, the signaling pathway linking 
upstream DNA sensors to TBK1 are poorly characterized. TBK1 associates with DDX3, a DEAD box 
RNA helicase, which regulates IFNβ transcription via IRF-3 [84,85]. In addition, TBK1 interacts with 
the exocyst protein Sec5 in a complex that includes the recently identified endoplasmic reticulum (ER) 
adaptor stimulator of interferon genes (STING) [69,88–90]. STING plays a central role in the signaling 
pathway  upstream  of  TBK1  following  HSV  infection  [69].  STING  also  interacts  with  the  ER 
translocon  components  Sec61β  and  TrapB  in  a  manner  essential  for  regulation  of  cytosolic  
DNA-induced type I IFN production, although the mechanistic understanding of this finding is not 
known [88]. In unstimulated cells, STING localizes to the ER and perhaps ER-associated mitochondria 
[90]. Following stimulation with cytosolic DNA and HSV-1, STING translocates to perinuclear foci, 
via the Golgi [88]. STING localizes partially to endosomes, particularly Sec5 positive structures [88], 
whilst another report has demonstrated that STING localizes to vesicular  structures, which are not 
peroxisomes, mitochondria, endosomes or autophagosomes [91]. Further work is required to clarify the 
precise subcellular localization of STING. What is clear is the essential role of STING in cytosolic 
DNA sensing pathways. Much less clear is the mechanisms or receptors which act upstream of STING. 
A growing number of DNA sensors have now been implicated and will be outlined below. 
3.5. DAI 
DNA-dependent activator of IFN-regulatory  factors (DAI) was among the  first of the cytosolic 
DNA sensors to be discovered. It is composed of two binding domains for left-handed, Z form DNA, 
although the protein can recognize B form DNA as well. When DAI was exogenously expressed in 
L929 cells, it increased type I IFN production in a dose dependent manner following stimulation by 
both B and Z form DNA. Similarly, knockdown of DAI with siRNA impaired type I IFN production in 
response to DNA, the 45 bp interferon stimulatory DNA (ISD) from  Listeria and the herpesvirus, 
HSV-1 [92,93]. The production of type-1 interferons by fibroblasts in response to HCMV was also 
found  to  be  dependent  on  DAI  [94].  DAI-knockout  mice  were  subsequently  generated,  and 
surprisingly, cells derived from DAI deficient mice respond normally to synthetic and viral dsDNA Viruses 2011, 3                         
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[92,95]. These results suggested that DAI might play a cell type specific, and redundant role in sensing 
cytoplasmic DNA, and that other sensors must also be necessary for inducing these responses.  
3.6. RNA Pol III 
As discussed above, both synthetic and viral RNA trigger the production of type I IFNs via RIG-I. 
Although, the RLRs are sensors of RNA, some data has suggested a role for this system in detection of 
DNA.  A  somewhat  surprising  finding  was  that  synthetic  B-form  dsDNA  can  also  induce  IFN 
production in human cells in a manner that was dependent on the RIG-I adapter molecule MAVS  
[52–54]. These findings suggested the existence of an unknown DNA sensor that would signal via 
MAVS. Recently, two independent studies have provided an explanation for these findings and shown 
that AT-rich DNA can be transcribed by RNA polymerase III into 5'-ppp RNA, which subsequently 
activates RIG-I [52,55]. This pathway was reported to be involved in type I IFN induction during EBV 
infections where the EBERs are transcribed by RNA polymerase III [56]. This indirect DNA-sensing 
system was also reported to be involved in induction of type I IFN following HSV-1 or Legionella 
infection [52,55,57]. 
3.7. LRRFIP1 
In addition to DAI and RNA Pol III, Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1) 
has recently been implicated as a regulator of DNA-driven innate immune signaling. LRRFIP1 was 
found  to  bind  to the  drosophila  homolog  flightless  I  and  play  a  role  in  actin  organization  during 
drosophila embrogenesis. In a study using Listeria monocytogenes to screen for potential cytosolic 
DNA sensing molecules, siRNA against LRRFIP1 was found to inhibit type I IFN production induced 
by the bacteria. The authors showed that the IFN response to VSV was dampened in these cells as 
well. Furthermore, knockdown of LRRFIP1 inhibited IFN production in response to polyI:C, and the 
synthetic DNA  species, poly(dG:dC) and poly(dA:dT), implicating LRRFIP1  in the recognition of 
both dsRNA and both B and Z form dsDNA. Surprisingly, this function is independent of RNA Pol III. 
LRRFIP1  does  not  regulate  IRF3  activation  but  instead  appears  to  regulate  a  novel  β-catenin-
dependent  coactivator  pathway.  LRRFIP1  binds  RNA  or  DNA  and  leads  to  phosphorylation  of 
β-Catenin,  which  subsequently  translocates  to  the  nucleus  where  it  associates  with  the  p300 
acetyltransferase  at  the  IFNβ1  promoter,  leading  to  increased  IFNβ  production  [101].  Although 
LRRFIP1 has been implicated in the recognition of both Listeria monocytogenes and VSV, further 
studies are needed in order to determine its role in sensing other viruses, particularly DNA viruses.  
3.8. IFI16 
While analyzing immune responses to a dsDNA region derived from the VV and HSV-1 genomes, 
Bowie et al. identified IFI16 as a DNA binding protein which interacted with these dsDNAs. IFI16 is a 
member of the PyHIN (pyrin and HIN200 domain-containing) protein  family. The PHYIN  family 
consists of  4  family  members:  IFIX, IFI16,  MNDA  and  AIM2.  All  contain  one  or  more  HIN200 
domains, which recognize DNA as well as a pyrin domain. Knockdown of IFI16 or p204 (a member of 
the murine PYHIN family) led to a reduction in IFNβ responses to these dsDNAs while responses to Viruses 2011, 3                         
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the  RNA  virus  SV  was  unaffected.  Although  IFI16  is  primarily  nuclear  in  most  cell  types,  in 
macrophages IFI16 also localized to the cytosolic compartment where it co-localized with dsDNA 
introduced via lipofectamine. Association of IFI16 with STING was required for the production of 
IFNβ in response to these DNA motifs. siRNA knockdown of IFI16, and its mouse homolog p204 led 
to a decrease in IRF3 and NF-κB activation and IFNβ gene induction following infection of cells with 
HSV-1 [102].  
3.9. DDX9 and 36 
Also in the family of DExD/H box RNA helicases, DHX9 and DHX36 have recently been shown to 
recognize and bind CpG-B and CpG-A DNA, respectively in plasmacytoid dendritic cells. Activation 
of DHX9 leads to IRF-7 activation and IFNα production, while activation of DHX36 leads to the 
activation of NF-κB and the production of IL-6 and TNFα. siRNA knockdown of DHX9 and DHX36 
inhibited cytokine production in response to the DNA virus HSV-1, while response to the RNA virus 
influenza A was unaffected [103].  
4. Inflammasomes 
Although the sensing of cytoplasmic DNA is linked to the transcriptional induction of type I IFN 
and  other  pro-inflammatory  cytokines,  cytosolic  DNA  has  also  been  shown  to  trigger  the  
caspase-1-dependent maturation of the pro-inflammatory cytokines IL-1β and IL-18 [104,105]. IL-1β, 
a close biological relative of TNFα, is involved in innate cell recruitment, activation of T-lymphocytes 
and induction of fever [106]. IL-18 increases the cytolytic activity and IFNγ production of natural 
killer (NK) cells and influences neutrophil recruitment and activation [106,107]. Growing evidence 
supports  the  importance  of  these  cytokines  in  anti-viral  defenses  [108,109].  Mice  lacking  either  
one of these cytokines have demonstrated enhanced susceptibility to influenza A virus and HSV-1 
infections [110]. Moreover, pretreating mice with IL-18 protects them from subsequent HSV-1 and 
VV challenge [111,112].  
In  contrast  to  type  I  IFNs  and  TNFα,  the  production  of  IL-1β  is  controlled  at  the  level  of 
transcription, translation, maturation and secretion [113,114]. Many cell stimuli including TLR-ligands 
activate the transcription of the pro-forms of IL-1β and IL-18. Unlike most other cytokines however, 
these pro-cytokines lack leader sequences and are retained in the cytoplasm rather than loaded into 
secretory  vesicles.  Maturation  (i.e.,  the  cleavage)  of  pro-IL-1β  and  pro-IL-18  is  catalyzed  by  the 
cysteine protease caspase-1 (formerly known as IL-1 converting enzyme). In resting cells, caspase-1 
itself is present as an inactive zymogen pro-caspase-1 [115]. A large „inflammasome protein complex‟ 
controls the activity of the inflammatory caspase-1 [115]. Several protein complexes have been shown 
to form inflammasomes upon recognizing specific stimuli. NLRPs 2 to 14, which contain a C-terminal 
LRR-rich domain, a central nucleotide-binding NACHT oligomerization domain, and an N-terminal 
protein–protein interaction pyrin domain (PYD) associate with the PYD containing adaptor molecule 
apoptosis-associated  speck-like  protein  (ASC;  also termed  pycard or  TMS1) [116].  ASC  links  the 
NLRP‟s  via  its  C-terminal  CARD  domain  to  the  CARD  domain  of  pro-caspase-1.  This  close 
association of pro-caspase-1 molecules is then believed to provoke self-cleavage into active caspase-1. Viruses 2011, 3                         
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Active  caspase-1  then  cleaves  pro-IL-1β  and  pro-IL18.  ASC  is  critical  for  caspase-1  activation  in 
response to many stimuli [106,107,115,117,118].  
4.1. AIM2 
Cytosolic  dsDNA  also  triggers  an  ASC  dependent  activation  of  caspase-1  resulting  in  the 
maturation  and  secretion  of  IL-1β  and  IL-18.  These  findings  suggested  the  existence  of  an 
inflammsome  complex  that  can  be  triggered  by  DNA.  Analysis  of  this  response  in  macrophages 
lacking  members  of  the  NLRs  revealed  normal  caspase-1  activation  in  these  cells.  Subsequent  
studies from several groups revealed that this response was instead dependent on AIM2 (Absent in 
melanoma-2),  an  interferon  inducible  protein  that  belongs  to  the  same  PYHIN  family  as  IFI16 
[105,119–121]. AIM2 recognizes cytosolic dsDNA of self and nonself origin including viral DNA via 
its HIN200 domain in a sequence-independent manner. Contrary to other cytosolic sensors of DNA, 
the recognition of DNA by AIM2 triggers the assembly of an inflammasome complex. Upon DNA 
binding, AIM2 likely undergoes oligomerization and associates with ASC via homotypic pyrin-pyrin 
domain interactions, which in turn recruits pro-caspase 1. Published data has shown that the AIM2 
inflammasome is an integral component of innate sensing of DNA viruses [109]. AIM2 is essential for 
the activation of caspase-1 and proteolytic processing of IL-1β and IL-18 in antigen presenting cells in 
response to infection with MCMV and VV. Furthermore, AIM2-ASC dependent IL-18 secretion and 
NK-cell activation is critical in the early control MCMV infection in vivo [105,109]. In addition to 
viruses, AIM2 has also been shown to recognize Francisella tularensis and as observed  for DNA 
viruses appears to be critical in early control of Francisella tularensis infection in vivo. Moreoever, 
AIM2 as well as NLRP3 and IPAF  function  in a redundant manner  in the recognition of  Listeria 
monocytogenes [109,122]. 
4.2. NLRP3 
In addition to the AIM2 inflammasome, a number of recent studies have shown that mice deficient 
in NLRP3 are more susceptible to virus infections, particularly RNA viruses [104,123,124]. Loss of 
NLRP3 was  found to attenuate the normal IL-1β and IL-18 responses to influenza  virus and was 
associated with diminished innate cell recruitment to the lung and increased pathology [123]. Further 
studies revealed that influenza‟s M2 protein, a proton-specific ion channel was needed to trigger the 
NLRP3 inflammasome [124]. Viral RNA has also been shown to trigger NLRP3 activation, although 
this is unlikely to be a direct RNA-NLRP3-interaction. The precise relationship between M2 and RNA 
in  NLRP3  activation  remains  to  be  clarified.  The  NLRP3  inflammasome  also  plays  a  role  in  the 
response to adenovirus, a DNA virus [104]. Peritoneal macrophages isolated from NLRP3 or ASC 
deficient  mice  exposed  to  adenovirus  are  unable to  secrete  mature  IL-1β  [104].  When  challenged  
in  vivo,  NLRP3  knockout  mice  had  reduced  levels  of  IL-1β,  IL-6,  CCL4  (MIP-1β)  and  CXCL10  
(IP-10) in the liver. Recently, a viral NLR homolog was identified in the dsDNA virus, KSHV. The 
KSHV  tegument  protein  ORF63  appears  to  be  an  NLR  homolog  that  can  inhibit  inflammasome 
activation  by  binding  to  NLRP1  and  NLRP3 [58].  Inflammasome  activation  suppresses  KSHV 
reactivation  from  latency,  suggesting  that  inflammasome  activation  and  IL-1  mediated  signaling 
facilitates  KSHV  latency.  These  observations  are  consistent  with  a  model  whereby  the  KSHV Viruses 2011, 3                         
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tegument  ORF63  protein  might  bind  NLRP3  and/or  NLRP1  to  block  the  detrimental  effects  of 
inflammasome activation.  
Intriguingly,  a  recent  study  has  revealed  a  role  for  IFI16  in  the  recognition  of  Kaposi  
sarcoma-associated herpesvirus (KSHV) in endothelial cells. IFI16 is known to recognize viral DNA 
in the cytosol and drive type I Interferon production, as discussed above. In endothelial cells however, 
IFI16 in the nucleus can sense the KSHV DNA and form a complex with the inflammasome adapter 
molecule  ASC.  These  findings  suggest  that  IFI16  can  form  an  inflammasome  complex  following 
recognition of nuclear DNA during infection with this virus [59]. Figure 2 portrays the cytosolic and 
nuclear receptors known to respond to viral pathogens and their downstream signal pathways. 
Figure 2. Cytosolic and Nuclear Pattern Recognition Receptors (PRRs). A multitude of 
DNA  sensors,  including  IFI16,  RNA  Polymerase  III,  DAI,  LRRFIP1,  and  DDX9/36 
recognize  DNA  and  drive  type  I  IFNs  and  cytokine  production.  RIG-I  and  MDA5 
recognize RNA in the cytosol. All of these molecules converge on STING in the case of 
DNA  or  MAVS  in  the  case  of  RNA.  STING  and  MAVS  then  engage  either  the  
TBK1-IRF3  or  the  IKKb-NFkB  pathways,  resulting  in  the  activation  of  type  I  IFN 
responses and inflammatory cytokines, respectively. AIM2 (which binds to dsDNA) and 
NLRP3  (which  can  respond  to  viral  RNA  (probably  indirectly))  act  in  the  cytosol  to 
promote the formation of a multiprotein inflammasome complex that contains the adaptor 
protein  ASC,  and  caspase-1.  IFI16  can  also  detect  DNA  in  the  nucleus  during  KSHV 
infection.  Nuclear  IFI16  engages  ASC  which  then  triggers  caspase-1  in  the  cytosol. 
Activation of caspase-1 results in the proteolytic cleavage of pro-IL-1β and pro-IL-18 to 
IL-1β and IL-18, respectively. The mature cytokines can then be released from the cell. 
 
 
5. Conclusions and Future Perspectives 
Over  the  past  decade our  understanding  of  how the  innate  immune  system  detects  viruses  and 
triggers antiviral responses has increased immensely. Our knowledge of what constitutes a  PAMP, Viruses 2011, 3                         
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once limited to classical TLR activators such as LPS, has recently expanded to include nucleic acids. 
This has led to the discovery of a variety of cytosolic RNA and DNA receptors and their downstream 
signaling  pathways.  Although  our  grasp  of  TLR  function  has  matured  significantly  over  the  past 
decade, a number of prominent questions remain regarding cytosolic and nuclear PRR signaling. First, 
many of the cytosolic sensors appear to play redundant roles  in  viral detection. Such overlapping 
defense  strategies  may  have  evolved  in  order  to  combat  viral  evasion  mechanisms.  Defining  the 
function  of  newly  identified  PRRs  in  immune  defense  to  viral  infection  is  an  important  step  in 
understanding their unique or ancillary contributions to pathogenesis.  
Secondly, it remains unclear how some nucleic acid sensors discriminate self from non-self. Just as 
RIG-I  recognizes  the  5‟  triphosphate  moiety  found  principally  on  viral  RNAs,  a  mechanism 
presumably exists allowing PRRs such as IFI16 to distinguish between virally derived and host DNA. 
Another question that must be addressed is how viral RNA and DNA is made accessible to PRRs. For 
instance, it is not well understood how nucleic acids are presented to cytosolic sensors in cases such as 
HSV infection where viral DNA is shielded by a capsid in the cytoplasm and replicates within the 
nucleus. As we explore these and other questions it is imperative that we apply our findings in human 
model systems. By encouraging cooperation between basic and clinical communities we can ensure 
that new discoveries are quickly translated into therapeutic strategies.  
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